News
Therapeutic Goods Administration Adj. Professor John Skerritt's interview on ABC Radio National on 9 January 2023
Read the transcript of Therapeutic Goods Administration Adjunct Professor John Skerritt's interview with Hamish Macdonald on ABC Radio National on 9 January 2023.
PBS co-payment reduction – What pharmacists need to know
A lower Pharmaceutical Benefits Scheme (PBS) general co-payment from 1 January 2023 will help ease cost-of-living pressures for Australians. Here’s what pharmacists need to know to support their customers.
National Cabinet Statement
See the below statement, released following the conclusion of National Cabinet on Saturday 16 July 2022.
Health Funding Facts update
The Australian Government announced a record $503 billion investment in our universal health system in the 2021–22 Budget. We’ve updated our Health Funding Facts tool to use the latest figures. Find out more about our key investment areas.
Affected by floods? Help is available
If you've been affected by the floods in New South Wales and Queensland there are a range of services you can access to stay on top of your health needs.
Soliris® (eculizumab) available on PBS from 1 March 2022
The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).
Have your say on a proposed National Medicines Traceability Framework
We are about to open a consultation about a potential National Medicines Traceability Framework (NMTF) for PBS medicines. If you are an industry participant of the medicine supply chain in Australia, you can take part. Find out how you can get involved and make a submission.
Review of the Guiding principles for medication management in residential aged care facilities and in the community
The Australian Commission on Safety and Quality in Health Carewill lead a review and update of the guiding principles for medication management in residential aged care facilities and in the community to support the safe and quality use of medicines.
New PBS listings for multiple sclerosis, asthma and diabetes medicines
The Australian Government has listed a range of medicines for treating multiple sclerosis, asthma and diabetes on the Pharmaceutical Benefits Scheme (PBS). The listings will provide valuable support for more than 51,800 Australians living with these conditions, saving them up to $29,000 a year.
New listing provides relief for Australians with severe eczema
The Government has added a life-changing new eczema medicine to the Pharmaceutical Benefits Scheme (PBS). The $270 million in funding to list the medicine will help up to 3,600 Australians over 12 years of age living with severe eczema.
Last updated: